Monopril and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Monopril (fosinopril sodium), especially for people who are female, 50-59 old, also take Vicodin, and have Arthritis.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Monopril. It is created by eHealthMe based on reports of 5,820 people who have side effects when taking Monopril from the FDA, and is updated regularly.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,966 drugs and 1,975 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,820 people reported to have side effects when taking Monopril.
Among them, 20 people (0.34%) have Dermatitis - atopic.

Could Monopril cause Dermatitis - atopic?

Among these 20 people:

What is the gender of people who have Dermatitis - atopic when taking Monopril? *

female: 100 %
male: 0.0 %

What is the age of people who have Dermatitis - atopic when taking Monopril? *

What are other drugs people take besides Monopril? *

What are other side effects people have besides Dermatitis - atopic? *

Nausea (feeling of having an urge to vomit): 17 people, 85.00%
Weight Decreased: 16 people, 80.00%
Sprains (an injury to the ligaments around a joint): 16 people, 80.00%
Road Traffic Accident: 16 people, 80.00%
Weakness: 16 people, 80.00%
Fall: 16 people, 80.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 16 people, 80.00%
Fainting (loss of consciousness and postural tone): 16 people, 80.00%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 16 people, 80.00%
Pain In Jaw: 16 people, 80.00%

What are the existing conditions these people have? *

Pain: 16 people, 80.00%
Metastases To Bone (cancer spreads to bone): 16 people, 80.00%
Breast Cancer: 16 people, 80.00%
Bone Pain: 16 people, 80.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 16 people, 80.00%
Constipation: 9 people, 45.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.00%
Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 5.00%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Monopril and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Monopril:

Monopril (5,910 reports)

Browse all side effects of Monopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,966 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,975 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosinopril sodium (the active ingredients of Monopril) and Monopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.